2703 篇
1106 篇
195323 篇
3431 篇
6334 篇
2259 篇
2858 篇
543 篇
29936 篇
10379 篇
3229 篇
776 篇
2320 篇
1331 篇
452 篇
753 篇
1393 篇
2663 篇
2752 篇
4124 篇
全球肝细胞癌治疗市场预测流行病学管道分析(2022-2027年)
Global Hepatocellular Carcinoma Treatment Market Forecast - Epidemiology Pipeline Analysis 2022-2027
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. Hepatocellular carcinoma constitutes more than 90% of the primary tumor of the liver. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection, accounting for ~50% of cases.
CHAPTER – 1: HEPATOCELLULAR CARCINOMA OVERVIEW
CHAPTER – 2: HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
CHAPTER - 3: HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
CHAPTER – 4: HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
CHAPTER – 5: HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW